Captivision (CAPT) Stock Chart & Stock Price History → Little-known biotech company just had groundbreaking results from a study (From Smallcaps Daily) (Ad) Free CAPT Stock Alerts $5.31 +0.11 (+2.12%) (As of 02:49 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Captivision Stock Price Performance5 Day Performance+5.78%1 Month Performance-10.76%3 Month Performance-20.75%6 Month Performance+227.78%Year-To-Date Performance+42.74% Receive CAPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Captivision and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Smallcaps DailyLittle-known biotech company just had groundbreaking results from a studyLearn how this company could see tremendous growth ahead with a novel broad-spectrum antiviral that has activity against RSV!Click here for the full report & ticker symbol CAPT Stock Chart for Wednesday, May, 22, 2024 CAPT Chart by TradingView Captivision Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2024$5.13$5.20+1.36%$5.23$5.0585,295 shs$149.86 million05/20/2024$5.02$5.13+2.19%$5.24$5.1058,116 shs$147.85 million05/17/2024$4.80$5.02+4.58%$5.39$4.8079,032 shs$144.68 million05/16/2024$4.80$4.80$4.93$4.7944,470 shs$138.34 million05/15/2024$4.53$4.80+5.96%$4.90$4.7439,023 shs$138.34 million05/14/2024$5.04$4.53-10.12%$5.09$4.5377,143 shs$130.56 million Get the Latest News and Ratings for CAPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Captivision and its competitors with MarketBeat's FREE daily newsletter. 05/13/2024$5.14$5.04-1.95%$5.22$5.0135,063 shs$145.24 million05/10/2024$5.19$5.14-0.96%$5.22$5.1461,354 shs$148.13 million05/09/2024$5.00$5.19+3.80%$5.23$5.0349,221 shs$149.57 million05/08/2024$4.94$5.00+1.21%$5.05$4.9431,971 shs$144.09 million05/07/2024$4.98$4.94-0.80%$5.05$4.9231,869 shs$142.37 million05/06/2024$5.05$4.98-1.38%$5.22$4.9420,796 shs$143.52 million05/03/2024$5.00$5.05+1.00%$5.06$4.9032,568 shs$145.53 million05/02/2024$4.85$5.00+3.09%$5.06$4.8836,595 shs$144.10 million05/01/2024$4.95$4.85-2.02%$5.00$4.8435,190 shs$139.78 million04/30/2024$5.08$4.95-2.56%$5.17$4.9216,119 shs$142.66 million04/29/2024$5.38$5.08-5.58%$5.40$5.0730,225 shs$146.41 million04/26/2024$5.02$5.38+7.17%$5.54$5.0657,903 shs$155.05 million04/25/2024$4.91$5.02+2.24%$5.07$4.9034,855 shs$144.68 million04/24/2024$5.86$4.91-16.21%$5.88$4.82113,065 shs$141.51 million04/23/2024$5.95$5.86-1.51%$5.90$5.7073,566 shs$168.89 million04/22/2024$4.64$5.95+28.23%$5.97$4.84175,455 shs$171.48 million04/19/2024$4.92$4.64-5.69%$4.90$4.6261,667 shs$133.72 million04/18/2024$4.95$4.92-0.61%$5.07$4.9132,816 shs$141.79 million04/17/2024$4.95$4.95$5.35$4.9489,874 shs$142.66 million04/16/2024$5.07$4.95-2.37%$5.12$4.8683,384 shs$142.66 million04/15/2024$5.12$5.07-0.98%$5.25$5.0763,744 shs$146.12 million04/12/2024$5.12$5.12$5.12$5.0557,869 shs$147.56 million04/11/2024$5.28$5.12-3.03%$5.25$5.1142,632 shs$147.56 million04/10/2024$5.59$5.28-5.55%$5.59$5.2838,325 shs$152.17 million04/09/2024$5.70$5.59-1.93%$5.75$5.5637,277 shs$161.10 million04/08/2024$5.80$5.70-1.72%$5.79$5.6722,882 shs$164.27 million04/05/2024$5.87$5.80-1.19%$5.90$5.8029,333 shs$167.14 million04/04/2024$5.82$5.87+0.86%$5.99$5.8458,135 shs$169.17 million04/03/2024$5.83$5.82-0.17%$6.04$5.7551,755 shs$167.73 million04/02/2024$6.12$5.83-4.74%$6.08$5.7056,662 shs$168.02 million04/01/2024$6.55$6.12-6.56%$6.46$6.1281,289 shs$176.38 million03/29/2024$6.55$6.55$6.55$6.4552,575 shs$188.77 million03/28/2024$6.54$6.55+0.15%$6.55$6.4552,494 shs$188.77 million03/27/2024$6.65$6.54-1.65%$6.67$6.5287,800 shs$188.48 millionLittle-known biotech company just had groundbreaking results from a study (Ad)Learn how this company could see tremendous growth ahead with a novel broad-spectrum antiviral that has activity against RSV!Click here for the full report & ticker symbol03/26/2024$6.51$6.65+2.15%$6.75$6.6087,566 shs$191.65 million03/25/2024$6.34$6.51+2.68%$6.68$6.28156,267 shs$187.62 million03/22/2024$5.65$6.34+12.21%$6.38$6.01119,992 shs$182.72 million03/21/2024$5.19$5.65+8.86%$5.65$5.00108,582 shs$162.83 million03/20/2024$5.21$5.19-0.38%$5.35$5.0849,678 shs$149.57 million03/19/2024$5.33$5.21-2.25%$5.39$5.1666,044 shs$150.15 million03/18/2024$5.25$5.33+1.52%$5.41$5.2751,817 shs$153.61 million03/15/2024$5.57$5.25-5.75%$5.72$5.2563,505 shs$151.29 million03/14/2024$5.80$5.57-3.97%$5.81$5.5039,393 shs$160.53 million03/13/2024$5.92$5.80-2.03%$5.96$5.7732,462 shs$167.16 million03/12/2024$5.87$5.92+0.85%$6.03$5.8829,515 shs$170.61 million03/11/2024$5.91$5.87-0.68%$6.23$5.8066,467 shs$169.17 million03/08/2024$6.33$5.91-6.64%$6.75$5.80139,712 shs$170.33 million03/07/2024$5.93$6.33+6.75%$6.37$6.0041,875 shs$182.43 million03/06/2024$6.14$5.93-3.42%$6.14$5.8780,169 shs$170.89 million03/05/2024$6.00$6.14+2.33%$6.34$6.0764,846 shs$176.96 million03/04/2024$6.35$6.00-5.51%$6.47$5.41152,490 shs$172.92 million03/01/2024$6.10$6.35+4.10%$6.40$6.0743,928 shs$182.99 million02/29/2024$5.81$6.10+4.99%$6.12$5.80106,360 shs$175.80 million02/28/2024$5.67$5.81+2.47%$6.06$5.67155,565 shs$167.44 million02/27/2024$6.03$5.67-5.97%$6.09$5.63175,411 shs$163.41 million02/26/2024$6.40$6.03-5.78%$6.27$5.92168,300 shs$173.79 million02/23/2024$6.70$6.40-4.48%$6.66$6.3287,337 shs$184.45 million02/22/2024$6.73$6.70-0.45%$6.95$6.65109,149 shs$193.09 million02/21/2024$7.30$6.73-7.81%$7.40$6.71182,737 shs$193.95 million Related Companies: Zalatoris II Acquisition Stock Price Chart Carbon Revolution Public Stock Price Chart Everest Consolidator Acquisition Stock Price Chart Alchemy Investments Acquisition Corp 1 Stock Price Chart TLGY Acquisition Stock Price Chart Valuence Merger Corp. I Stock Price Chart Integrated Rail and Resources Acquisition Stock Price Chart Marblegate Acquisition Stock Price Chart TPB Acquisition Co. I Stock Price Chart Black Mountain Acquisition Stock Price Chart Receive CAPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Captivision and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CAPT) was last updated on 5/22/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Presidential candidate you should REALLY be worried aboutStansberry ResearchThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarLittle-known biotech company just had groundbreaking results from a studySmallcaps DailyBill Clinton Backing Biden Replacement???The Freeport SocietyThe Crypto 9-5 Escape PlanCrypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsNew Options need New Trading StrategiesNetpicks Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Captivision Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.